These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 25339676

  • 1. T-bet:Eomes balance, effector function, and proliferation of cytomegalovirus-specific CD8+ T cells during primary infection differentiates the capacity for durable immune control.
    Popescu I, Pipeling MR, Shah PD, Orens JB, McDyer JF.
    J Immunol; 2014 Dec 01; 193(11):5709-5722. PubMed ID: 25339676
    [Abstract] [Full Text] [Related]

  • 2. IL-12-Dependent Cytomegalovirus-Specific CD4+ T Cell Proliferation, T-bet Induction, and Effector Multifunction during Primary Infection Are Key Determinants for Early Immune Control.
    Popescu I, Pipeling MR, Mannem H, Shah PD, Orens JB, Connors M, Migueles SA, McDyer JF.
    J Immunol; 2016 Jan 15; 196(2):877-90. PubMed ID: 26663780
    [Abstract] [Full Text] [Related]

  • 3. Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients.
    Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF.
    J Infect Dis; 2011 Dec 01; 204(11):1663-71. PubMed ID: 22021622
    [Abstract] [Full Text] [Related]

  • 4. Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets.
    Hassouneh F, Lopez-Sejas N, Campos C, Sanchez-Correa B, Tarazona R, Pera A, Solana R.
    Int J Mol Sci; 2017 Jun 29; 18(7):. PubMed ID: 28661443
    [Abstract] [Full Text] [Related]

  • 5. Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection.
    Pipeling MR, West EE, Osborne CM, Whitlock AB, Dropulic LK, Willett MH, Forman M, Valsamakis A, Orens JB, Moller DR, Lechtzin N, Migueles SA, Connors M, McDyer JF.
    J Immunol; 2008 Jul 01; 181(1):546-56. PubMed ID: 18566421
    [Abstract] [Full Text] [Related]

  • 6. Persistent cytomegalovirus-specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients.
    Shlobin OA, West EE, Lechtzin N, Miller SM, Borja M, Orens JB, Dropulic LK, McDyer JF.
    J Immunol; 2006 Feb 15; 176(4):2625-34. PubMed ID: 16456025
    [Abstract] [Full Text] [Related]

  • 7. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW, Brooimans RA, van der Holt B, Sintnicolaas K, van Doornum G, Niesters HG, Löwenberg B, Cornelissen JJ.
    Cytometry B Clin Cytom; 2008 Jul 15; 74(4):211-20. PubMed ID: 18454493
    [Abstract] [Full Text] [Related]

  • 8. An optimized IFN-γ ELISpot assay for the sensitive and standardized monitoring of CMV protein-reactive effector cells of cell-mediated immunity.
    Barabas S, Spindler T, Kiener R, Tonar C, Lugner T, Batzilla J, Bendfeldt H, Rascle A, Asbach B, Wagner R, Deml L.
    BMC Immunol; 2017 Mar 07; 18(1):14. PubMed ID: 28270111
    [Abstract] [Full Text] [Related]

  • 9. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
    Albiero E, Amati E, Baumeister E, Einsele H, Grigoleit GU, Rodeghiero F.
    J Immunother; 2016 Mar 07; 39(9):329-342. PubMed ID: 27631893
    [Abstract] [Full Text] [Related]

  • 10. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.
    Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, Cherepnev G, Proesch S, Reinke P, Volk HD, Lehmkuhl H, Kern F.
    J Exp Med; 2005 Apr 04; 201(7):1031-6. PubMed ID: 15795239
    [Abstract] [Full Text] [Related]

  • 11. High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control.
    Akulian JA, Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF.
    Am J Transplant; 2013 Jan 04; 13(1):146-56. PubMed ID: 23016698
    [Abstract] [Full Text] [Related]

  • 12. Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant.
    López-Oliva MO, Martinez V, Buitrago A, Jiménez C, Rivas B, Escuin F, Santana MJ, Selgas R, Bellón T.
    Transplantation; 2014 Apr 27; 97(8):839-45. PubMed ID: 24345896
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
    Zandvliet ML, van Liempt E, Jedema I, Veltrop-Duits LA, Willemze R, Guchelaar HJ, Falkenburg JH, Meij P.
    Cytotherapy; 2010 Nov 27; 12(7):933-44. PubMed ID: 20078388
    [Abstract] [Full Text] [Related]

  • 15. Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells.
    Smith C, Elhassen D, Gras S, Wynn KK, Dasari V, Tellam J, Tey SK, Rehan S, Liu YC, Rossjohn J, Burrows SR, Khanna R.
    Blood; 2012 Oct 18; 120(16):3237-45. PubMed ID: 22942184
    [Abstract] [Full Text] [Related]

  • 16. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
    Vaz-Santiago J, Lulé J, Rohrlich P, Jacquier C, Gibert N, Le Roy E, Betbeder D, Davignon JL, Davrinche C.
    J Virol; 2001 Sep 18; 75(17):7840-7. PubMed ID: 11483727
    [Abstract] [Full Text] [Related]

  • 17. Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.
    Giménez E, Muñoz-Cobo B, Solano C, Amat P, de la Cámara R, Nieto J, López J, Remigia MJ, Garcia-Noblejas A, Navarro D.
    Transpl Infect Dis; 2015 Jun 18; 17(3):361-70. PubMed ID: 25850900
    [Abstract] [Full Text] [Related]

  • 18. Rapid generation of CMV pp65-specific T cells for immunotherapy.
    Bao L, Sun Q, Lucas KG.
    J Immunother; 2007 Jun 18; 30(5):557-61. PubMed ID: 17589296
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous monitoring of cytomegalovirus-specific antibody and T-cell levels in seropositive heart transplant recipients.
    Carbone J, Lanio N, Gallego A, Kern F, Navarro J, Muñoz P, Alonso R, Catalán P, Fernández-Yáñez J, Palomo J, Ruiz M, Fernández-Cruz E, Sarmiento E.
    J Clin Immunol; 2012 Aug 18; 32(4):809-19. PubMed ID: 22371292
    [Abstract] [Full Text] [Related]

  • 20. Cytomegalovirus-specific CD8+ T cells do not develop in all renal transplant patients at risk of virus infection.
    Christmas SE, Halliday D, Lawton N, Wang H, Abdalla I, Masters J, Hassan RL, Hart IJ, Khan N, Smith J, Hammad A, Bakran A.
    Transpl Immunol; 2009 Dec 18; 22(1-2):99-104. PubMed ID: 19635559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.